Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
MALVERN, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel […]
Conduent Recognized as a 2024 Leader in HR Benefits Administration by NelsonHall
NelsonHall says Conduent provides integrated health, financial wellness and total rewards solutions focused on increasing employee engagement Conduent named an […]
SFL – Fourth Quarter 2023 Results
Preliminary Q4 2023 results and increased quarterly cash dividend to $0.26 per share Hamilton, Bermuda, February 14, 2024. SFL Corporation […]
TSX News -
Microbix Reports Record Results for Q1 Fiscal 2024
MISSISSAUGA, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, […]
Perella Weinberg to Present at the Bank of America 2024 Financial Services Conference
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today […]
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
LOS ALTOS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]
Tower Semiconductor Reports 2023 Fourth Quarter and Full Year Financial Results
MIGDAL HAEMEK, Israel, Feb. 14, 2024 (GLOBE NEWSWIRE) — Tower Semiconductor (NASDAQ: TSEM & TASE: TSEM) reports today its results […]
Blue Point Brewing Announces Its 4th Annual Shakedown on Main Street Festival Featuring Headliners Shaggy, Bryce Vine, and B.o.B
PATCHOGUE, New York, Feb. 14, 2024 (GLOBE NEWSWIRE) — Blue Point Brewing Company, Long Island’s original craft brewery and subsidiary […]
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
Pro-forma cash, cash equivalents and marketable securities expected to fund the Company into 2027 and through clinical readouts from ongoing […]
Opthea Completes Enrollment in First Pivotal Trial with Sozinibercept
COAST trial is evaluating the superiority of sozinibercept combined with EYLEA®(aflibercept) over EYLEA alone in wet AMD Enrollment of second […]
